Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.115 GBX | +15.37% | +27.14% | +27.14% |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Valuation
Fiscal Period: November | 2021 | 2022 |
---|---|---|
Capitalization 1 | 38.31 | 8.272 |
Enterprise Value (EV) 1 | 36.96 | 10.62 |
P/E ratio | -11 x | -3.14 x |
Yield | - | - |
Capitalization / Revenue | 5,181,681 x | 1,012,901 x |
EV / Revenue | 4,998,796 x | 1,300,570 x |
EV / EBITDA | -24.6 x | -4.36 x |
EV / FCF | -24,901,172 x | -3,936,921 x |
FCF Yield | -0% | -0% |
Price to Book | 10.7 x | 5.19 x |
Nbr of stocks (in thousands) | 174,150 | 174,150 |
Reference price 2 | 0.2200 | 0.0475 |
Announcement Date | 4/26/22 | 5/2/23 |
Income Statement Evolution (Annual data)
Fiscal Period: November | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales | - | 7.394 | 8.167 |
EBITDA 1 | -0.2504 | -1.5 | -2.438 |
EBIT 1 | -0.2507 | -1.586 | -2.611 |
Operating Margin | - | -21.45% | -31.97% |
Earnings before Tax (EBT) 1 | -0.2507 | -2.347 | -2.722 |
Net income 1 | -0.2507 | -2.166 | -2.503 |
Net margin | - | -29.29% | -30.65% |
EPS | - | -0.0200 | -0.0151 |
Free Cash Flow | - | -1.484 | -2.698 |
FCF margin | - | -20.07% | -33.04% |
FCF Conversion (EBITDA) | - | - | - |
FCF Conversion (Net income) | - | - | - |
Dividend per Share | - | - | - |
Announcement Date | 7/14/21 | 4/26/22 | 5/2/23 |
Balance Sheet Analysis
Fiscal Period: November | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | 0 | - | 2.35 |
Net Cash position 1 | - | 1.35 | - |
Leverage (Debt/EBITDA) | -0.0109 x | - | -0.9637 x |
Free Cash Flow | - | -1.48 | -2.7 |
ROE (net income / shareholders' equity) | - | -124% | -85% |
ROA (Net income/ Total Assets) | - | -16.7% | -20.9% |
Assets 1 | - | 12.96 | 11.97 |
Book Value Per Share 2 | 0.2100 | 0.0200 | 0.0100 |
Cash Flow per Share | - | 0.0200 | 0 |
Capex 1 | 0 | 0.17 | 0.13 |
Capex / Sales | - | 2.27% | 1.57% |
Announcement Date | 7/14/21 | 4/26/22 | 5/2/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.14% | 11.23M | |
-17.06% | 14.96B | |
+17.02% | 11.36B | |
+20.88% | 8.63B | |
+46.43% | 8.57B | |
+7.39% | 8.89B | |
-8.42% | 8.31B | |
-12.78% | 6.89B | |
-15.97% | 6.61B | |
+27.91% | 6.44B |
- Stock Market
- Equities
- LST Stock
- Financials Light Science Technologies Holdings Plc